4.7 Editorial Material

Endometrial Indian hedgehog expression is decreased in women with endometriosis

Journal

FERTILITY AND STERILITY
Volume 95, Issue 8, Pages 2738-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2011.05.018

Keywords

Indian hedgehog; endometriosis; endometrium; progesterone

Funding

  1. Intramural NIH HHS [Z01 HD000637-14] Funding Source: Medline

Ask authors/readers for more resources

Nuclear and cytoplasmic endometrial expression of Indian hedgehog increased from the late proliferative to mid and late secretory phases in 26 healthy volunteers compared with 30 women with endometriosis. The abnormal expression of Indian hedgehog protein in women with endometriosis suggests a resistance to P action. (Fertil Steril (R) 2011;95:2738-41. (C)2011 by American Society for Reproductive Medicine.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

The Hypothalamic-Pituitary-Thyroid Axis in Cushing Syndrome Before and After Curative Surgery

Skand Shekhar, Raven McGlotten, Sunyoung Auh, Kristina Rother, Lynnette K. Nieman

Summary: The study revealed that abnormal thyroid function, likely mediated by subnormal nocturnal TSH levels, is prevalent in patients with Cushing syndrome. This abnormality can be reversed after cure.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Letter Oncology

In Reply

Sriram Gubbi, Lisa M. Cordes, Joanna Klubo-Gwiezdzinska, Ravi A. Madan, Lynnette K. Nieman, James L. Gulley, Jaydira Del Rivero

Summary: This letter to the editor responds to comments by Salinas and colleagues on experiences with identification of adrenal insufficiency among patients on immune checkpoint inhibitor therapy.

ONCOLOGIST (2021)

Article Endocrinology & Metabolism

Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals

Sriram Gubbi, Ranganath Muniyappa, Susmeeta T. Sharma, Shivraj Grewal, Raven McGlotten, Lynnette K. Nieman

Summary: Short-term administration of mifepristone improved adipose and hepatic insulin sensitivity in obese individuals with hyperglycemia but without hypercortisolism.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

Approach to the Patient Treated with Steroidogenesis Inhibitors

Frederic Castinetti, Lynnette K. Nieman, Martin Reincke, John Newell-Price

Summary: Steroidogenesis inhibitors are used to control hypercortisolism in Cushing's syndrome in various situations, but daily management can be challenging due to potential side effects and difficulties in defining eucortisolism. Monitoring of biological markers and proper combination of drugs are important aspects of treatment.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients

Regin Jay Mallari, Jai Deep Thakur, Garni Barkhoudarian, Amy Eisenberg, Amanda Rodriguez, Sarah Rettinger, Pejman Cohan, Lynnette Nieman, Daniel F. Kelly

Summary: This study describes the predictive performance of preoperative biochemical and imaging data on postoperative remission and clinical characteristics in patients with presumed Cushing's disease. The use of strict biochemical thresholds can improve surgical remission rates and avoid recommending surgery to patients with equivocal biochemical data.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Neurosciences

The NIMH Intramural Longitudinal Study of the Endocrine and Neurobiological Events Accompanying Puberty: Protocol and rationale for methods and measures

Katherine M. Cole, Shau-Ming Wei, Pedro E. Martinez, Tuong-Vi Nguyen, Michael D. Gregory, J. Shane Kippenhan, Philip D. Kohn, Steven J. Soldin, Lynnette K. Nieman, Jack A. Yanovski, Peter J. Schmidt, Karen F. Berman

Summary: This study aims to investigate the impact of increased sex steroid production during puberty on neurodevelopment, and explores the relationships with various endocrine events through longitudinal research, as well as assessing the effects of gonadal development on brain structure and function.

NEUROIMAGE (2021)

Review Endocrinology & Metabolism

Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing's Syndrome

Lynnette K. Nieman

Summary: Endogenous Cushing's syndrome is associated with various complications and shortened lifespan. The clinical presentation is diverse and often results in delayed diagnosis and treatment. Further research is needed to develop better tests, faster diagnosis, and optimized treatments. This review focuses on CS caused by excessive ACTH production and discusses the regulation of ACTH synthesis and secretion, as well as the clinical applications of CS screening tests and their relationship to cortisol dynamics and pathophysiology. Gaps in current understanding are also highlighted to encourage further research.

ENDOCRINE REVIEWS (2022)

Editorial Material Endocrinology & Metabolism

Septic Shock: A Disruptor of the Hypothalamic-Adrenal Axis as We Know It

Lynnette K. Nieman

ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Hypercoagulability in Cushing's syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols

Richard A. Feelders, Lynnette K. Nieman

Summary: Cushing's syndrome is associated with a higher risk of venous thromboembolism due to a hypercoagulable state. Postoperative VTE risk remains elevated even several months after surgery. The hypercoagulable state in CS may be caused by an imbalance in pro- and anticoagulant activity.

PITUITARY (2022)

Review Endocrinology & Metabolism

Selective progesterone receptor modulators and reproductive health

Lynnette K. Nieman

Summary: This article reviews the history, current availability, therapeutic promise, and safety concerns of selective progesterone receptor modulators (SPRMs) and progesterone antagonists. Despite the interest in synthesizing these compounds, only a few have undergone clinical trials and been commercialized. Mifepristone is well tolerated and effective for first trimester pregnancy termination, while ulipristal acetate is effective for emergency contraception. However, long-term use of these drugs may cause abnormal liver enzymes, highlighting the need for further research and alternative formulations.

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2022)

Article Cell Biology

Pituitary adenomas evade apoptosis via noxa deregulation in Cushing's disease

David T. Asuzu, Reinier Alvarez, Patrick A. Fletcher, Debjani Mandal, Kory Johnson, Weiwei Wu, Abdel Elkahloun, Paul Clavijo, Clint Allen, Dragan Maric, Abhik Ray-Chaudhury, Sharika Rajan, Zied Abdullaev, Diana Nwokoye, Kenneth Aldape, Lynnette K. Nieman, Constantine Stratakis, Stanko S. Stojilkovic, Prashant Chittiboina

Summary: This study identifies the transcriptomic signatures of Cushing's disease adenomas compared to adjacent normal cells and reveals the key proteins and their regulatory mechanisms in Cushing's disease adenomas. Further experimental results indicate that selective proteasomal inhibition with bortezomib stabilizes proteins and induces apoptosis in Cushing's disease adenoma cells, showing potential as an anti-tumor agent.

CELL REPORTS (2022)

Article Endocrinology & Metabolism

Ovine CRH Stimulation and 8 mg Dexamethasone Suppression Tests in 323 Patients With ACTH-Dependent Cushing's Syndrome

Henrik Elenius, Raven McGlotten, Lynnette K. Nieman

Summary: Determining the etiology of ACTH-dependent Cushing's syndrome can be difficult. The corticotropin-releasing hormone stimulation test and the high-dose dexamethasone suppression test have good performance in distinguishing Cushing's disease from ectopic ACTH syndrome. The combination of these tests can accurately diagnose approximately 64% of patients with Cushing's disease, obviating the need for the expensive and less widely available inferior petrosal sinus sampling (IPSS).

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Article Endocrinology & Metabolism

Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification

Ken K. Y. Ho, Ursula B. B. Kaiser, Phillippe Chanson, Monica Gadelha, John Wass, Lynnette Nieman, Andrew Little, Manish K. K. Aghi, Lori Raetzman, Kalmon Post, Gerald Raverot, Alexander D. D. Borowsky, Dana Erickson, Justo P. P. Castano, Edward R. R. Laws, Maria Chiara Zatelli, Jill Sisco, Laura Esserman, Kevin C. J. Yuen, Martin Reincke, Shlomo Melmed

Summary: In the 2022 WHO Classification, pituitary adenomas are reclassified as neuroendocrine tumours (NETs), which are mostly benign. A comprehensive clinical classification system is needed to guide prognosis, therapy, and outcomes for pituitary adenoma patients.

NATURE REVIEWS ENDOCRINOLOGY (2023)

Article Endocrinology & Metabolism

Patient and Provider Perspectives on Postsurgical Recovery of Cushing Syndrome

Rachel Acree, Caitlin M. Miller, Brent S. Abel, Nicola M. Neary, Karen Campbell, Lynnette K. Nieman

Summary: Patients and physicians have different perspectives on the time needed for recovery and useful coping mechanisms during the recovery process in Cushing syndrome. Some patients lack sufficient information and preparation for the postsurgical experience, leading to dissatisfaction. Poor communication between physicians and patients may contribute to decreased HRQOL during recovery.

JOURNAL OF THE ENDOCRINE SOCIETY (2021)

Article Obstetrics & Gynecology

The short-term effects of estradiol, raloxifene, and a phytoestrogen in women with perimenopausal depression

Peter J. Schmidt, Shau-Ming Wei, Pedro E. Martinez, Rivka R. Ben Dor, Gioia M. Guerrieri, Paula P. Palladino, Veronica L. Harsh, Howard J. Li, Paul Wakim, Lynnette K. Nieman, David R. Rubinow

Summary: In women with perimenopause-related depression (PMD), the study found that transdermal 17-beta estradiol (TE) had beneficial effects on depression ratings compared to raloxifene and Rimostil, with no significant differences from placebo. Cognitive testing showed no active treatment group performed better than placebo.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2021)

No Data Available